Effect of SB203580 on γ-aminobutyric acid B receptor 1 expression in spinal cord during early phase of neuropathic pain

WU Junzhen,DU Dongping,JIANG Wei
2010-01-01
Abstract:Objective To investigate the effects of SB203580,an inhibitor of p38 MAPK,on γ-aminobutyric acid B receptor 1 [GABAB(1)] receptor expression in the dorsal horn of a neuropathic pain model,so as to understand the possible mechanism by which the microglia induces neuropathic pain.Methods Thirty-two male adult Sprague-Dawley rats,weighing 200-260 g,were used in this study.Rats were all intrathecally catheterized and assigned to either left lumbar 5(L5) spinal nerve ligation (SNL) or sham surgery,and they were randomly divided into 4 groups (n=8 each);group Ⅰ SNL+intrathecal (IT) 0.1%SB203580 10 μL;group Ⅱ SNL+IT vehicle (2% DMSO) 10 μL;group Ⅲ sham operation+IT 0.1%SB203580 10 μL;and group Ⅳ sham operation+IT vehicle (2% DMSO) 10 μL.The 50% Paw withdrawal threshold (50% PWT) to von Frey hair simulation was measured before operation and on the 1st,3rd and 7th day after operation.The GABAB(1) expression in dorsal horn was examined by Western blotting analysis on the 7th day.Results The 50% PWT and the GABAB(1a) expression in the dorsal horn were significantly lower in SNL group than in sham operation group (P<0.01).Intrathecal administration of SB203580 significantly inhibited the SNL-induced mechanical allodynia and increased the GABAB(1a) expression to even higher than the baseline level.Conclusion The mechanisms of neuropathic pain mediated by microglia activation may be related to the inhibition of the pre-synaptic GABAB(1a) receptor activation,which may provide new effective means to treat neuropathic pain.(Shanghai Med J,2010,33:308-311)
What problem does this paper attempt to address?